PDL BioPharm (PDLI) Responds to Third Point's 13D Filing
Tweet Send to a Friend
In Today's 8-K Filing From PDL BioPharm (Nasdaq: PDLI) :
Mr. Daniel Loeb
Chief Executive Officer
This article: 290 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Mr. Daniel Loeb
Chief Executive Officer
This article: 290 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
